The NPAR, calculated as the ratio of neutrophil percentage to serum albumin concentration, has demonstrated significant predictive value for adverse outcomes in a range of conditions, including heart failure [8, 9], acute myocardial infarction [10, 11, 12], and atrial fibrillation [13, 14], as well as in patients in cardiac intensive care units [15, 16, 17], those with acute kidney injury [18] or severe infection [19, 20], and those undergoing peritoneal dialysis [21, 22, 23]. The gene discussed is ALB; the disease is infection.